Abstract:Liver fibrosis is a complex pathological process controlled by a variety of cells, mediators and signaling pathways. Hepatic stellate cells play a central role in the development of liver fibrosis. In chronic liver disease, hepatic stellate cells undergo dramatic phenotypic activation and acquire fibrogenic properties. This review focuses on the pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. They enter the cell cycle under the influence of various triggers. The "Initiation" phase of hepatic stellate cells activation overlaps and continues with the "Perpetuation" phase, which is characterized by a pronounced inflammatory and fibrogenic reaction. This is followed by a resolution phase if the injury subsides. Knowledge of these pathophysiological mechanisms paved the way for drugs aimed at preventing the development and progression of liver fibrosis. In this respect, impairments in intracellular signaling, epigenetic changes and cellular stress response can be the targets of therapy where the goal is to deactivate hepatic stellate cells. Potential antifibrotic therapy may focus on inducing hepatic stellate cells to return to an inactive state through cellular aging, apoptosis, and/or clearance by immune cells, and serve as potential antifibrotic therapy. It is especially important to prevent the formation of liver cirrhosis since the only radical approach to its treatment is liver transplantation which can be performed in only a limited number of countries.

Research progression on the activation of hepatic stellate cells

Regulatory Long Non-Coding RNAs of Hepatic Stellate Cells in Liver Fibrosis (Review)

Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies

Clearance of Activated Stellate Cells for Hepatic Fibrosis Regression: Molecular Basis and Translational Potential

Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis

Activation and Inhibition of Human HSCs and the Related Molecular Mechanisms

Liver Fibrosis: the Status Quo and the Prospect

Hepatic stellate cells as key target in liver fibrosis

Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy

Epigenetic Mechanisms in Hepatic Stellate Cell Activation During Liver Fibrosis and Carcinogenesis

Immunological characteristics of hepatic stellate cells

Research Advances in Immune Cellular Pathogenesis in Liver Fibrosis

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis

Research progress on roles of immune factors in development of hepatic fibrosis

Advances in Studies on Apoptotic Mechanism of Hepatic Stellate Cells

Cellular Mechanisms in Liver Fibrosis Regression

Signal Transduction of Hepatic Stellate Cells in Liver Fibrosis

Mechanisms of hepatic stellate cell activation